Opportunity Information: Apply for RFA NS 14 004

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Centers Without Walls for Collaborative Research in the Epilepsies Sudden Unexpected Death in Epilepsy (SUDEP) (U01)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders.
  • This funding opportunity was created on Sep 20, 2013 and posted on Sep 20, 2013.
  • Applicants must submit their applications by Mar 10, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
  • The number of recipients for this funding is limited to 1 candidate(s).
  • Eligible applicants include: Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) State governments Others (see text field entitled Additional Information on Eligibility for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses County governments City or township governments Small businesses Special district governments.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Apply for RFA NS 14 004

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The NIH funding opportunity RFA-NS-14-004, titled "Centers Without Walls for Collaborative Research in the Epilepsies: Sudden Unexpected Death in Epilepsy (SUDEP) (U01)," is a discretionary, health-focused cooperative agreement designed to push SUDEP research forward through tightly coordinated, multi-institution teamwork. The central goal is to speed up progress on three fronts: clarifying the biological and physiological mechanisms that lead to SUDEP, identifying and validating risk factors in people with epilepsy, and moving toward practical intervention strategies that could prevent SUDEP. Rather than supporting isolated projects, the announcement is structured to build a collaborative, center-like program that functions across sites (a "Center Without Walls"), with multiple research components deliberately linked together so they can share data, expertise, methods, and infrastructure.

This FOA uses the U01 cooperative agreement mechanism, which generally means the NIH expects substantial scientific involvement from the funding institute compared with a standard investigator-initiated grant. In practice, applicants should be prepared for a more interactive relationship with NIH program staff, including coordinated milestones, shared governance expectations, and an emphasis on collaboration and deliverables. The application format reflects that center-style approach: linked applications are required and must include an Administrative Core plus multiple Scientific Projects, with the option to add additional Cores if they are necessary to support the research aims (for example, a data management core, clinical phenotyping core, biostatistics core, neurophysiology core, pathology core, or similar shared resource). The Administrative Core is expected to provide leadership, coordination across participating sites, communication plans, oversight of progress, and integration across projects so the overall program functions as a single cohesive effort rather than a collection of independent studies.

The research focus is specifically SUDEP, a devastating outcome in epilepsy that remains incompletely understood. The FOA is aimed at accelerating discovery about the underlying mechanisms that contribute to SUDEP, which can include neurologic, cardiac, respiratory, autonomic, genetic, and systems-level pathways, as well as interactions among these systems. It also targets the identification of risk factors in individuals with epilepsy, which typically implies clinically meaningful predictors that can be measured, tracked, and used to stratify risk. Finally, it emphasizes working toward prevention, meaning the program should have a clear line of sight to interventions, whether they involve monitoring approaches, therapeutic strategies, clinical management changes, device-based solutions, or other preventive concepts that can be tested and refined as evidence develops.

From an administrative standpoint, the opportunity was posted September 20, 2013, with an original and current closing date of March 10, 2014, and an archive date of April 10, 2014. The NIH estimated total funding for the initiative at $3,000,000 and anticipated making one award. There is no cost sharing or matching requirement. The CFDA listing associated with the program is 93.853, which corresponds to Extramural Research Programs in the Neurosciences and Neurological Disorders. Because only one award was expected, the FOA effectively describes a highly competitive, flagship-type center effort, where the proposed team, integration plan, and likelihood of producing actionable advances in SUDEP would be central to review.

Eligibility is broad and includes many types of domestic U.S. organizations, such as public and private institutions of higher education, nonprofit organizations (with and without 501(c)(3) status), state and local governments (including counties, cities/townships, special district governments), independent school districts, public housing authorities/Indian housing authorities, tribal governments and tribal organizations, small businesses, and for-profit organizations (other than small businesses). The FOA explicitly includes a wide range of institution types that often participate in NIH programs, such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), along with faith-based or community-based organizations where appropriate. Importantly, non-U.S. entities are also eligible, including foreign organizations and foreign institutions, and foreign components of U.S. organizations are permitted as allowed under NIH policy, meaning the collaboration model can extend internationally if it strengthens the science and the program can justify that structure.

Overall, this FOA is best understood as an NIH-driven attempt to concentrate expertise and resources into a single, highly integrated collaborative network dedicated to SUDEP. The required combination of an Administrative Core and multiple Scientific Projects signals that NIH wanted applicants to propose not just strong individual studies, but a coordinated program where different disciplines and sites collectively address SUDEP mechanisms, risk prediction, and prevention in a way that would be difficult to accomplish through separate, unconnected grants. For full details, the archived announcement was provided via the NIH Grants Guide at http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-14-004.html, and NIH Office of Extramural Research contact points were listed for technical access or linking issues.

Frequently Asked Questions (FAQs): NIH RFA-NS-14-004 (U01) SUDEP Centers Without Walls

What is the funding opportunity RFA-NS-14-004?

RFA-NS-14-004 is an NIH funding opportunity titled "Centers Without Walls for Collaborative Research in the Epilepsies: Sudden Unexpected Death in Epilepsy (SUDEP) (U01)." It supports a highly coordinated, multi-institution research program focused on accelerating SUDEP research through shared infrastructure, linked studies, and cross-site collaboration.

What does "Centers Without Walls" mean in this FOA?

"Centers Without Walls" refers to a center-like program that operates across multiple sites rather than being housed at a single institution. The intent is to create a tightly integrated network where projects and cores deliberately share data, methods, expertise, and infrastructure so the overall effort functions as one cohesive program.

What is the main purpose of this SUDEP funding opportunity?

The FOA is designed to speed progress in SUDEP research by focusing on three connected goals: (1) clarifying the biological and physiological mechanisms leading to SUDEP, (2) identifying and validating risk factors in people with epilepsy, and (3) moving toward practical prevention or intervention strategies.

What research topics or systems are relevant to SUDEP mechanisms under this FOA?

The FOA highlights that SUDEP mechanisms may involve neurologic, cardiac, respiratory, autonomic, genetic, and systems-level pathways, as well as interactions among these systems. Programs can be designed to address one or more of these areas as part of an integrated plan.

What kinds of outcomes is NIH aiming for with this program?

NIH is aiming for actionable advances that improve understanding of SUDEP mechanisms, produce clinically meaningful and measurable risk predictors, and create a clear pathway toward prevention strategies, including concepts that can be tested and refined as evidence develops.

What grant mechanism is used, and what does U01 imply?

This FOA uses the U01 cooperative agreement mechanism. In general, that means NIH expects substantial scientific involvement from the funding institute compared with a typical investigator-initiated grant. Applicants should be prepared for an interactive relationship with NIH program staff and an emphasis on collaboration, milestones, governance, and deliverables.

How is the application expected to be structured?

The FOA requires linked applications that include an Administrative Core plus multiple Scientific Projects. Additional Cores may be included if they are necessary to support the research aims.

What is the role of the Administrative Core?

The Administrative Core is expected to provide leadership and coordination across participating sites, define communication plans, oversee progress, and integrate the projects so the program operates as a single cohesive effort rather than separate, independent studies.

What additional cores might be included in an application?

The FOA notes that applicants may add additional cores if needed to support the overall program, such as a data management core, clinical phenotyping core, biostatistics core, neurophysiology core, pathology core, or other shared resource cores aligned with the proposed aims.

Does the FOA support individual stand-alone projects?

No. The FOA is structured to support a collaborative, center-like program with multiple linked components. The emphasis is on integration and shared resources rather than isolated projects.

What does the FOA mean by "risk factors" in people with epilepsy?

The FOA points toward clinically meaningful predictors that can be measured and tracked and that may be used to stratify SUDEP risk. The expectation is that the program will identify and validate risk factors, not simply propose hypothetical predictors.

What does "prevention" include in the context of this FOA?

Prevention is framed as having a clear line of sight to practical interventions that could prevent SUDEP. The FOA mentions possibilities such as monitoring approaches, therapeutic strategies, clinical management changes, device-based solutions, or other prevention concepts that can be tested and refined as evidence develops.

When was this opportunity posted, and what were the key dates?

The FOA was posted on September 20, 2013. The original and current closing date was March 10, 2014. The archive date was April 10, 2014.

How much funding was expected to be available, and how many awards were anticipated?

NIH estimated total funding at $3,000,000 and anticipated making one award. This effectively positions the program as a single, flagship-type collaborative center effort.

Is there a cost sharing or matching requirement?

No. The FOA states there is no cost sharing or matching requirement.

What is the CFDA number associated with this program?

The CFDA listing associated with this FOA is 93.853, which corresponds to Extramural Research Programs in the Neurosciences and Neurological Disorders.

Who is eligible to apply?

Eligibility is broad and includes many types of U.S. organizations such as public and private institutions of higher education, nonprofit organizations (with and without 501(c)(3) status), state and local governments (including counties, cities/townships, and special district governments), independent school districts, public housing authorities/Indian housing authorities, tribal governments and tribal organizations, small businesses, and for-profit organizations (other than small businesses).

Are minority-serving institutions and community-based organizations included in eligibility?

Yes. The FOA explicitly includes institution types that often participate in NIH programs, including HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and AANAPISIs, along with faith-based or community-based organizations where appropriate.

Are foreign organizations eligible, and can the program include international components?

Yes. Non-U.S. entities are eligible, including foreign organizations and foreign institutions. Foreign components of U.S. organizations are also permitted as allowed under NIH policy, enabling international collaboration when it strengthens the science and is justified in the program structure.

What does it mean that NIH expected to make only one award?

Because only one award was anticipated, the FOA describes a highly competitive opportunity where the proposed team, integration plan, and likelihood of producing coordinated, actionable advances in SUDEP are central to the overall concept.

Where can the archived FOA be found?

The archived announcement was provided via the NIH Grants Guide at http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-14-004.html.

Where were technical help or access questions directed?

The FOA noted that NIH Office of Extramural Research contact points were listed for technical access or linking issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: Disaster Mental Health Intervention Research Center (P60)

Previous opportunity: Physics at the Information Frontier

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA NS 14 004

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA NS 14 004) also looked into and applied for these:

Funding Opportunity
Disaster Mental Health Intervention Research Center (P60) Apply for RFA MH 14 090

Funding Number: RFA MH 14 090
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Ryan White Part B HIV Care Grant Program Apply for HRSA 14 047

Funding Number: HRSA 14 047
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
Center for Evaluation and Coordination of Training and Research (CECTR) in Tobacco Regulatory Science (U54) Apply for RFA OD 13 117

Funding Number: RFA OD 13 117
Agency: National Institutes of Health
Category: Health
Funding Amount: $2,000,000
COOPERATIVE AGREEMENT WITH THE PAN AMERICAN HEALTH ORGANIZATION (PAHO) Protecting the Advances in Polio, Rubella and Measles Elimination Strengthening Immunization Programs in the Americas Apply for CDC RFA GH14 1401

Funding Number: CDC RFA GH14 1401
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Neurological Sciences Academic Development Award (K12) Apply for PAR 13 362

Funding Number: PAR 13 362
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Nutrition and Alcohol Related Health Outcomes (R01) Apply for PA 13 359

Funding Number: PA 13 359
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Nutrition and Alcohol Related Health Outcomes (R03) Apply for PA 13 360

Funding Number: PA 13 360
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Nutrition and Alcohol Related Health Outcomes (R21) Apply for PA 13 361

Funding Number: PA 13 361
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Rural Health Network Development (RHND) Grant Program Apply for HRSA 14 044

Funding Number: HRSA 14 044
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $300,000
NEI Translational Research Program (TRP) on therapy for Visual Disorders (R24) Apply for PAR 13 370

Funding Number: PAR 13 370
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,750,000
Patient Centered Outcomes Research (PCOR) for Treatment Options in Uterine Fibroids Developing a Prospective Multi Center Practice based Clinical Registry (P50) Apply for RFA HS 14 006

Funding Number: RFA HS 14 006
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $4,000,000
Local Capacity Initiative Apply for RFI 486 14 00001

Funding Number: RFI 486 14 00001
Agency: Thailand USAID Bangkok
Category: Health
Funding Amount: Case Dependent
Health Communication Project Apply for RFA 391 14 000001

Funding Number: RFA 391 14 000001
Agency: Pakistan USAID Islamabad
Category: Health
Funding Amount: $24,500,000
AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF) Apply for HRSA 14 049

Funding Number: HRSA 14 049
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: Case Dependent
MEASURE Evaluation Phase IV Apply for SOL OAA 14 000005

Funding Number: SOL OAA 14 000005
Agency: Agency for International Development
Category: Health
Funding Amount: $181,000,000
NIBIB Biomedical Technology Resource Centers (P41) Apply for PAR 13 376

Funding Number: PAR 13 376
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U01) Apply for RFA TR 13 003

Funding Number: RFA TR 13 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Basic Research in the Pathogenesis of HIV Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R21) Apply for RFA HL 14 029

Funding Number: RFA HL 14 029
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Basic Research in the Pathogenesis of HIV Related Heart, Lung, and Blood (HLB) Diseases in Adults and Children (R01) Apply for RFA HL 14 024

Funding Number: RFA HL 14 024
Agency: National Institutes of Health
Category: Health
Funding Amount: $499,999
Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions (R21) Apply for PAR 13 380

Funding Number: PAR 13 380
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA NS 14 004", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.